AMSCA: a sector-wide voice for the peak consumer, research & treatment organisations working to improve outcomes for people affected by melanoma and skin cancer
The working party updating the 'Clinical Practice Guidelines for the Diagnosis and Management of Melanoma' is now seeking comment from clinicians and the community.
This year’s #MelanomaMarch campaign, which was the largest ever, raised vital funds to support the updating of these guidelines.
The first six chapters of the Guidelines have now been updated and are open for public consultation until 30 June.
Additional chapters will be released for public consultation over the coming months.
The clinical guidelines working party is supported by Melanoma Institute Australia and Cancer Council Australia.
To provide comments on the updated Guidelines, please go to the yellow 'Public Consultation' section on this page > https://t.co/2oJ5Ny1XTZ
#MelanomaClinicalGuidelines
Great to have AMSCA Chair & @Melanoma_MRV consumer Chair @AButtonSloan presenting at their annual scientific exchange meeting. Discussed the AMSCA consensus statement on targeted skin cancer screening program, MRV consumer updates & data collection changes for 2025.
@melanoma_MRV held its annual public forum last night. Always good to hear the about the year's achievements from research @McArthurGrant and consumer @AButtonSloan perspectives.
AMSCA's founding member! 🌟
Join us at MRV's Annual Scientific Exchange Meeting on Nov 7, in person or online. Don’t miss key updates, debates, & insights in melanoma research!
Register ➡️ https://t.co/DREoJBaAPo
MRV's annual Scientific Exchange Meeting is on this Thursday 7th November. All welcome. Hope to see you in person or online. Register here: https://t.co/C55jcubTl0
Our consumer, research, clinical, professional colleges and community Alliance members at #AMC2024
All dedicated and working towards to improving outcomes for #melanoma & skin cancer patients.
Looking forward to presenting at this premier event #AMC2024 on @AMSCA_Mel
Join us for the consumer/researcher debate session 'Patient advocacy and consumer representation are just a tick box exercise'—and don’t forget to cast your vote at the end!
https://t.co/35qCFcuqw7
ACRF ACEMID is proud to announce that we've won the @eurekaprizes for Excellence in Interdisciplinary Scientific Research.
This prestigious award recognises our team's dedication and innovative work in uniting diverse scientific fields to advance #melanoma research.
We are delighted to share AMSCA member @MelanomaACEMID, led by @hpsoyer, is a finalist for the @eurekaprizes for Excellence in Interdisciplinary Scientific Research!
⬇️⬇️⬇️
https://t.co/LE5nWt7UzN
@AnneECust was the first keynote speaker for the final day of #ASDR2024
Her interesting talk focused on #Melanoma risk assessment using genetic & traditional risk factors, and how people perceive, and often dichotomise their risk.
@DaffodilCentre@Sydney_Uni@AsdrResearch
Prof Pascale Guitera, faculty member @MelanomaAus & Professor @Sydney_Uni is presenting ‘Alternative treatment for lentigo maligna: review of evidence & the RADICAL trial’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney.
Register: https://t.co/UlASGg3aFD
👁️ The 2024 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit program is now available!
5 International speakers
11 Australian #ocularmelanoma experts
4 Ocular melanoma consumers
Sat 15 June - Registration is free!
Watch from anywhere worldwide!
https://t.co/NeGwd4a7do
📣 It’s with great excitement that we have launched a 3D total body imaging system in Orange, NSW.
Our regional sites are vital to allow regional Australians access to innovative technology, research and clinical trials for melanoma early detection.
#WorldMelanomaDay shines a spotlight on #melanoma & recognises all impacted. @ProfGLongMIA & @ProfRScolyerMIA have the honour of being 2024 @ausoftheyear, a platform to raise awareness, change tanning culture, promote sun safety & establish a targeted national screening program.
Prof @MonikaJanda is one of the chief investigators with @MelanomaACEMID and a valued member of the Australian Melanoma & Skin Cancer Alliance.
On behalf of the eleven nation-wide member organisations, we extend our congratulations.
👁️ The 2024 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit program is now available!
5 International speakers
11 Australian #ocularmelanoma experts
4 Ocular melanoma consumers
Sat 15 June - Registration is free!
Watch from anywhere worldwide!
https://t.co/NeGwd4a7do
@TrialsCentre@RachaelMorton12 et al identify 12 clinical quality indicators for best practice guidelines for early management of #melanoma - an important step in the creation of Australian Melanoma Clinical Outcomes Registry (MelCOR)
Learn more: https://t.co/AwNb09GuXk
As a Stage III #melanoma patient, what are your thoughts on adjuvant immunotherapy? Risks vs benefits. Health economics PhD candidate @_AnnLiv with the NHMRC Clinical Trials Centre @TrialsCentre is keen to know your views via this important online survey.
https://t.co/o8TDqqPLHb
Great to have @AMCA_Mel members @melanomasupport and @amenzies9 from @MelanomaAus attending this important conference. GPs are crucial to educating patients about #sunsmart behaviours and diagnosing #skincancers especially #melanoma.
@melanomasupport is delighted to be attending the Skin Cancer College Australasia Congress 2021 for GPs. Great program and diverse speakers.
Our team is looking forward to meeting many of the attendees so come over to our booth and say hello.
#skincancer#melanoma
#Melanoma patients & carers are invited to participate in an important survey that will form the basis of Australia’s first-ever landmark "The State of the Nation – A Report into Melanoma". Your support is vital. Please RT!
https://t.co/tnQNFY1YWV